Cedar Brook Financial Partners, LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 187 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cedar Brook Financial Partners, LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$50,773
-12.9%
130,5220.0%0.01%
-7.1%
Q2 2023$58,278
-32.2%
130,522
+24.4%
0.01%
-36.4%
Q1 2023$86,002
-37.9%
104,881
+18.2%
0.02%
-43.6%
Q4 2022$138,450
-9.6%
88,7500.0%0.04%
-20.4%
Q3 2022$153,094
-0.6%
88,7500.0%0.05%
+2.1%
Q2 2022$154,000
-51.7%
88,7500.0%0.05%
-42.2%
Q1 2022$319,000
+17.3%
88,750
+62.8%
0.08%
+18.6%
Q4 2021$272,000
-30.3%
54,5000.0%0.07%
-40.2%
Q3 2021$390,000
-22.8%
54,5000.0%0.12%
-19.9%
Q2 2021$505,000
-0.2%
54,5000.0%0.15%
-16.6%
Q1 2021$506,000
+5.0%
54,5000.0%0.18%
+2.3%
Q4 2020$482,000
-24.3%
54,500
-0.7%
0.17%
-31.6%
Q3 2020$637,000
-57.0%
54,9000.0%0.25%
-62.1%
Q2 2020$1,480,000
+265.4%
54,900
+0.7%
0.66%
+192.9%
Q1 2020$405,000
+195.6%
54,500
+31.3%
0.22%
+287.9%
Q4 2019$137,000
+61.2%
41,5000.0%0.06%
+56.8%
Q3 2019$85,000
-30.3%
41,5000.0%0.04%
-33.9%
Q2 2019$122,000
-21.3%
41,5000.0%0.06%
-25.3%
Q1 2019$155,000
-6.6%
41,5000.0%0.08%
-25.7%
Q4 2018$166,00041,5000.10%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders